Cascade Investment Group’s Edwards Lifesciences EW Stock Holding History

Cascade Investment Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Hold	3,091	–	–	0.16%	129
2026 Q1	$248K	Buy	3,091 +126	+4%	+$10.4K	0.16%	126
2025 Q4	$253K	Hold	2,965	–	–	0.17%	120
2025 Q3	$231K	Hold	2,965	–	–	0.15%	129
2025 Q2	$232K	Hold	2,965	–	–	0.16%	122
2025 Q1	$215K	Hold	2,965	–	–	0.17%	120
2024 Q4	$219K	Sell	2,965 -180	-6%	-$12.6K	0.16%	130
2024 Q3	$208K	Sell	3,145 -2,105	-40%	-$153K	0.15%	126
2024 Q2	$485K	Sell	5,250 -285	-5%	-$25.2K	0.38%	61
2024 Q1	$529K	Sell	5,535 -500	-8%	-$42K	0.4%	61
2023 Q4	$460K	Buy	6,035 +300	+5%	+$20.9K	0.37%	68
2023 Q3	$397K	Hold	5,735	–	–	0.37%	63
2023 Q2	$541K	Sell	5,735 -20	-0.3%	-$1.74K	0.49%	50
2023 Q1	$476K	Hold	5,755	–	–	0.47%	60
2022 Q4	$429K	Buy	+5,755	New	+$444K	0.45%	68

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Cascade Investment Group's EW Position: Q2 2026 in Review

Cascade Investment Group held its Edwards Lifesciences (EW) position steady in Q2 2026 at 3,091 shares worth $280K. The position accounts for 0.16% of the portfolio, ranked #129.

Cascade Investment Group first reported a position in EW in Q4 2022 and has held it in 15 quarters since. The position peaked at $541K in Q2 2023. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Cascade Investment Group held 3,091 shares of Edwards Lifesciences worth $280K as of Q2 2026.
Cascade Investment Group left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.16% of Cascade Investment Group's portfolio in Q2 2026, its #129 holding.
Cascade Investment Group first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 15 quarters since.
Cascade Investment Group's Edwards Lifesciences position peaked at $541K in Q2 2023.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cascade Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.